Narrative updates are currently in beta.

Back to narrative

Update shared on04 Aug 2025

Fair value Increased 6.06%
AnalystConsensusTarget's Fair Value
US$292.25
12.8% overvalued intrinsic discount
04 Aug
US$329.80
Loading
1Y
42.7%
7D
-4.1%

The upward revision in Fabrinet’s analyst price target primarily reflects a higher expected future P/E multiple rather than any significant change in revenue growth forecasts, lifting the consensus fair value from $275.56 to $292.25.


What's in the News


  • Fabrinet completed the repurchase of 162,133 shares for $34.77 million, representing 0.45% of shares, from December 28, 2024 to March 28, 2025.
  • The company has now repurchased a total of 3,766,133 shares for $337.76 million, representing 10.22% of shares, under the buyback announced in August 2017.

Valuation Changes


Summary of Valuation Changes for Fabrinet

  • The Consensus Analyst Price Target has risen from $275.56 to $292.25.
  • The Future P/E for Fabrinet has risen from 23.23x to 24.62x.
  • The Consensus Revenue Growth forecasts for Fabrinet remained effectively unchanged, moving only marginally from 14.9% per annum to 15.0% per annum.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.